Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Jul, 14 2025
Oct, 22 2025
Nov, 24 2025
Feb, 7 2026
Sep, 24 2025